Stories about Gastroesophageal reflux disease

Subscribe to Gastroesophageal reflux disease

09.11.2020 – 12:00

OrbusNeich
OrbusNeich® Medical and P+F Products & Features® announce new partnership

Hong Kong (ots/PRNewswire) - Introducing a new portfolio of heart valve products aiming to restore health and extend life OrbusNeich and P+F today announced they have entered into an agreement for the exclusive distribution and manufacturing of a range of innovative minimally invasive heart valve products in the Asia Pacific region, including China, Japan, Taiwan, ...

more
16.09.2019 – 19:15

Santen
Santen Makes Waves at ESCRS 2019 With Significant Expansion Into Surgical Devices and Publication of Real-world Evidence in Dry Eye Disease

Geneva (ots/PRNewswire) - Santen EMEA's significant expansion into the surgical devices arena is underlined by the company's activities at this year's European Society of Cataract and Refractive Surgeons (ESCRS) congress. In addition to the launch of a new monofocal, hydrophobic intraocular lens (IOL), xact(TM) ...

more
18.06.2019 – 12:37

HiDoc Technologies GmbH

5
Berlin-based Digital Health Company Cara Care Raises $7M Series A Led by Johnson & Johnson Innovation - JJDC, Inc. (JJDC) and Asabys Partners

Our press section
One document
more
03.12.2018 – 09:56

Grünenthal Gruppe
Grünenthal closes deal with AstraZeneca for Nexium and Vimovo

Aachen, Germany (ots) - Grünenthal today announced the successful completion of its acquisition of European rights to Nexium and global (ex US and Japan) rights to Vimovo from AstraZeneca for a total consideration of up to US$ 922 m (EUR 811 m). "Today is an important day for Grünenthal," said Gabriel Baertschi, CEO Grünenthal. "This transaction represents a significant step towards our vision of creating a world free ...

more
30.10.2018 – 08:43

Grünenthal Group
Grünenthal agrees US$ 922 m deal with AstraZeneca for Nexium and Vimovo

Aachen (ots) - - Biggest single investment in Grünenthal's history that will significantly strengthen the company's leading position in pain management - Gastroprotective therapies to address a high unmet medical need [1] in pain patients on non-steroidal anti-inflammatory drugs (NSAIDs) Grünenthal today announced that it has agreed to acquire AstraZeneca's European ...

more

1